Clinical Trial Update: Post-Market Surveillance Study of the TM Ardis Interbody Fusion System [Phase 4]

View source ↗

Summary

Post-market surveillance Phase 4 study update for the TM Ardis Interbody Fusion System completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease

Drugs mentioned

• TM Ardis Interbody Fusion System

Snippet

Sponsor: Zimmer Biomet | Conditions: Degenerative Disc Disease | Phase 4 | Status: COMPLETED